EGFR exon 2-7 deletion + EGFR amplification

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

EGFR exon 2-7 deletion + EGFR amplification	Non Small Cell Lung Cancer	EGFR exon 2-7 deletion + EGFR amplification	Non Small Cell Lung Cancer	EGFR inhibitor Resistant: C3 – Early Trials EGFR inhibitor Resistant : C3	EGFR inhibitor Resistant: C3 – Early Trials EGFR inhibitor Resistant : C3
EGFR exon 2-7 deletion + EGFR amplification	Glioblastoma	EGFR exon 2-7 deletion + EGFR amplification	Glioblastoma	bevacizumab + osimertinib Sensitive: C3 – Early Trials bevacizumab + osimertinib Sensitive : C3	bevacizumab + osimertinib Sensitive: C3 – Early Trials bevacizumab + osimertinib Sensitive : C3

Associations